questionsmedicales.fr
Composés hétérocycliques
Composés hétérocycliques à cycles fusionnés
Composés hétérobicycliques
Indolizine
Indolizidines
Alcaloïdes indoliques
Alcaloïdes formés par condensation de sécologanine et de tryptamine
Alcaloïdes de Vinca
Vincristine
Vincristine : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
2
Vincristine
Cancer
Diagnostic
Tests de laboratoire
Imagerie médicale
Vincristine
Symptômes
2
Effets secondaires
Neuropathie
Vincristine
Douleur
Neuropathie
Vincristine
Prévention
2
Prévention
Effets secondaires
Vincristine
Évaluation médicale
Vincristine
Préparation au traitement
Traitements
2
Chimiothérapie
Vincristine
Prednisone
Administration intraveineuse
Vincristine
Chimiothérapie
Complications
2
Complications
Infections
Vincristine
Problèmes cardiaques
Vincristine
Surveillance médicale
Facteurs de risque
2
Facteurs de risque
Neuropathie
Vincristine
Antécédents médicaux
Vincristine
Neurologie
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Vincristine : Questions médicales les plus fréquentes",
"headline": "Vincristine : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Vincristine : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-27",
"dateModified": "2025-02-21",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Vincristine"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Alcaloïdes de Vinca",
"url": "https://questionsmedicales.fr/mesh/D014748",
"about": {
"@type": "MedicalCondition",
"name": "Alcaloïdes de Vinca",
"code": {
"@type": "MedicalCode",
"code": "D014748",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.496.500.500.681.827"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Vincristine",
"alternateName": "Vincristine",
"code": {
"@type": "MedicalCode",
"code": "D014750",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Wenjian Yang",
"url": "https://questionsmedicales.fr/author/Wenjian%20Yang",
"affiliation": {
"@type": "Organization",
"name": "Hematological Malignancies Program and Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA."
}
},
{
"@type": "Person",
"name": "Deqing Pei",
"url": "https://questionsmedicales.fr/author/Deqing%20Pei",
"affiliation": {
"@type": "Organization",
"name": "Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA."
}
},
{
"@type": "Person",
"name": "Cheng Cheng",
"url": "https://questionsmedicales.fr/author/Cheng%20Cheng",
"affiliation": {
"@type": "Organization",
"name": "Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA."
}
},
{
"@type": "Person",
"name": "William E Evans",
"url": "https://questionsmedicales.fr/author/William%20E%20Evans",
"affiliation": {
"@type": "Organization",
"name": "Hematological Malignancies Program and Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA."
}
},
{
"@type": "Person",
"name": "Richard H Ho",
"url": "https://questionsmedicales.fr/author/Richard%20H%20Ho",
"affiliation": {
"@type": "Organization",
"name": "Vanderbilt University Medical Center, Nashville, TN."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer.",
"datePublished": "2023-03-02",
"url": "https://questionsmedicales.fr/article/36862289",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s40259-023-00585-7"
}
},
{
"@type": "ScholarlyArticle",
"name": "Particle bombardment-assisted peptide-mediated gene transfer for highly efficient transient assay.",
"datePublished": "2023-04-06",
"url": "https://questionsmedicales.fr/article/37024962",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13104-023-06320-3"
}
},
{
"@type": "ScholarlyArticle",
"name": "Advancements in ocular gene therapy delivery: vectors and subretinal, intravitreal, and suprachoroidal techniques.",
"datePublished": "2022-09-19",
"url": "https://questionsmedicales.fr/article/36062410",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/14712598.2022.2121646"
}
},
{
"@type": "ScholarlyArticle",
"name": "Adapter-Mediated Transduction with Lentiviral Vectors: A Novel Tool for Cell-Type-Specific Gene Transfer.",
"datePublished": "2022-09-30",
"url": "https://questionsmedicales.fr/article/36298713",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/v14102157"
}
},
{
"@type": "ScholarlyArticle",
"name": "A next-generation iPSC-derived forebrain organoid model of tauopathy with tau fibrils by AAV-mediated gene transfer.",
"datePublished": "2022-09-08",
"url": "https://questionsmedicales.fr/article/36160042",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.crmeth.2022.100289"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés hétérocycliques",
"item": "https://questionsmedicales.fr/mesh/D006571"
},
{
"@type": "ListItem",
"position": 3,
"name": "Composés hétérocycliques à cycles fusionnés",
"item": "https://questionsmedicales.fr/mesh/D000072471"
},
{
"@type": "ListItem",
"position": 4,
"name": "Composés hétérobicycliques",
"item": "https://questionsmedicales.fr/mesh/D006574"
},
{
"@type": "ListItem",
"position": 5,
"name": "Indolizine",
"item": "https://questionsmedicales.fr/mesh/D007212"
},
{
"@type": "ListItem",
"position": 6,
"name": "Indolizidines",
"item": "https://questionsmedicales.fr/mesh/D054836"
},
{
"@type": "ListItem",
"position": 7,
"name": "Alcaloïdes indoliques",
"item": "https://questionsmedicales.fr/mesh/D026121"
},
{
"@type": "ListItem",
"position": 8,
"name": "Alcaloïdes formés par condensation de sécologanine et de tryptamine",
"item": "https://questionsmedicales.fr/mesh/D046948"
},
{
"@type": "ListItem",
"position": 9,
"name": "Alcaloïdes de Vinca",
"item": "https://questionsmedicales.fr/mesh/D014748"
},
{
"@type": "ListItem",
"position": 10,
"name": "Vincristine",
"item": "https://questionsmedicales.fr/mesh/D014750"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Vincristine - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Vincristine",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Vincristine",
"description": "Comment la vincristine est-elle utilisée dans le diagnostic ?\nQuels tests précèdent l'administration de vincristine ?",
"url": "https://questionsmedicales.fr/mesh/D014750?mesh_terms=Gene+Transfer+Techniques#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Vincristine",
"description": "Quels sont les effets secondaires de la vincristine ?\nLa vincristine cause-t-elle des douleurs ?",
"url": "https://questionsmedicales.fr/mesh/D014750?mesh_terms=Gene+Transfer+Techniques#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Vincristine",
"description": "Peut-on prévenir les effets secondaires de la vincristine ?\nY a-t-il des recommandations avant le traitement par vincristine ?",
"url": "https://questionsmedicales.fr/mesh/D014750?mesh_terms=Gene+Transfer+Techniques#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Vincristine",
"description": "Avec quels médicaments la vincristine est-elle souvent combinée ?\nComment la vincristine est-elle administrée ?",
"url": "https://questionsmedicales.fr/mesh/D014750?mesh_terms=Gene+Transfer+Techniques#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Vincristine",
"description": "Quelles complications peuvent survenir avec la vincristine ?\nLa vincristine peut-elle causer des problèmes cardiaques ?",
"url": "https://questionsmedicales.fr/mesh/D014750?mesh_terms=Gene+Transfer+Techniques#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Vincristine",
"description": "Qui est à risque d'effets indésirables de la vincristine ?\nLes antécédents médicaux influencent-ils le traitement par vincristine ?",
"url": "https://questionsmedicales.fr/mesh/D014750?mesh_terms=Gene+Transfer+Techniques#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment la vincristine est-elle utilisée dans le diagnostic ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vincristine n'est pas un outil de diagnostic, mais un traitement pour des cancers diagnostiqués."
}
},
{
"@type": "Question",
"name": "Quels tests précèdent l'administration de vincristine ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins et des examens d'imagerie sont effectués pour évaluer la maladie."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires de la vincristine ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires incluent neuropathie, constipation, et fatigue."
}
},
{
"@type": "Question",
"name": "La vincristine cause-t-elle des douleurs ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut provoquer des douleurs neuropathiques chez certains patients."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les effets secondaires de la vincristine ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des mesures préventives incluent une surveillance étroite et des médicaments pour les symptômes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des recommandations avant le traitement par vincristine ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une évaluation médicale complète est recommandée avant le traitement."
}
},
{
"@type": "Question",
"name": "Avec quels médicaments la vincristine est-elle souvent combinée ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle est souvent combinée avec la prednisone et d'autres agents chimiothérapeutiques."
}
},
{
"@type": "Question",
"name": "Comment la vincristine est-elle administrée ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vincristine est administrée par voie intraveineuse, généralement en cycle."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec la vincristine ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des infections, des troubles neurologiques et des problèmes gastro-intestinaux."
}
},
{
"@type": "Question",
"name": "La vincristine peut-elle causer des problèmes cardiaques ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Bien que rare, des problèmes cardiaques peuvent survenir, nécessitant une surveillance."
}
},
{
"@type": "Question",
"name": "Qui est à risque d'effets indésirables de la vincristine ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les patients âgés et ceux avec des antécédents de neuropathie sont à risque accru."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux influencent-ils le traitement par vincristine ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de maladies neurologiques peuvent affecter le traitement."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 21/02/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Hematological Malignancies Program and Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Publications dans "Vincristine" :
3 publications dans cette catégorie
Affiliations :
Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Publications dans "Vincristine" :
3 publications dans cette catégorie
Affiliations :
Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Publications dans "Vincristine" :
3 publications dans cette catégorie
Affiliations :
Hematological Malignancies Program and Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Publications dans "Vincristine" :
3 publications dans cette catégorie
Affiliations :
Vanderbilt University Medical Center, Nashville, TN.
Publications dans "Vincristine" :
2 publications dans cette catégorie
Affiliations :
Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Publications dans "Vincristine" :
2 publications dans cette catégorie
Affiliations :
Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Publications dans "Vincristine" :
2 publications dans cette catégorie
Affiliations :
Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, 1081 HV Amsterdam, The Netherlands.
Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Publications dans "Vincristine" :
2 publications dans cette catégorie
Affiliations :
Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, 1081 HV Amsterdam, The Netherlands.
Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
Publications dans "Vincristine" :
2 publications dans cette catégorie
Affiliations :
Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, 1081 HV Amsterdam, The Netherlands.
Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
Publications dans "Vincristine" :
2 publications dans cette catégorie
Affiliations :
Departamento de Ciencias Básicas de la Salud, Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos, Alcorcón, Spain.
Unidad Asociada al Instituto de Química Medica (IQM) del Consejo Superior de Investigaciones Científicas (CSIC), Universidad Rey Juan Carlos, Alcorcón, Spain.
High Performance Research Group in Experimental Pharmacology (Pharmakom-URJC), URJC, Alcorcón, Spain.
Publications dans "Vincristine" :
2 publications dans cette catégorie
Affiliations :
Departamento de Ciencias Básicas de la Salud, Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos, Alcorcón, Spain.
Unidad Asociada al Instituto de Química Medica (IQM) del Consejo Superior de Investigaciones Científicas (CSIC), Universidad Rey Juan Carlos, Alcorcón, Spain.
High Performance Research Group in Experimental Pharmacology (Pharmakom-URJC), URJC, Alcorcón, Spain.
Publications dans "Vincristine" :
2 publications dans cette catégorie
Affiliations :
Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, PR China.
Publications dans "Vincristine" :
2 publications dans cette catégorie
Affiliations :
Department of Psychiatry, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China; Mental Health Institute of the Second Xiangya Hospital, Central South University, Chinese National Clinical Research Center on Mental Disorders (xiangya), Chinese National Technology Institute on Mental Disorders, Hunan Key Laboratory of Psychiatry and Mental Health, Changsha, Hunan 410011, China.
Publications dans "Vincristine" :
2 publications dans cette catégorie
Affiliations :
Division of Pulmonary Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.
Publications dans "Vincristine" :
2 publications dans cette catégorie
Affiliations :
Division of Pulmonary Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.
The Materials Science and Engineering Program, College of Engineering and Applied Science, University of Cincinnati, Cincinnati, OH, United States.
Center for Lung Regenerative Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.
Publications dans "Vincristine" :
2 publications dans cette catégorie
Affiliations :
Division of Pulmonary Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.
Publications dans "Vincristine" :
2 publications dans cette catégorie
Affiliations :
Division of Pulmonary Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.
Publications dans "Vincristine" :
2 publications dans cette catégorie
Affiliations :
Division of Pulmonary Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.
Division of Pulmonary and Critical Care and Sleep Medicine, Department of Internal Medicine, University of Cincinnati, Cincinnati, OH, United States.
Publications dans "Vincristine" :
2 publications dans cette catégorie
Affiliations :
The Materials Science and Engineering Program, College of Engineering and Applied Science, University of Cincinnati, Cincinnati, OH, United States.
Publications dans "Vincristine" :
Recombinant adeno-associated viruses (AAVs) have emerged as promising gene delivery vehicles resulting in three US Food and Drug Administration (FDA) and one European Medicines Agency (EMA)-approved A...
A centrifugation-assisted peptide-mediated gene transfer (CAPT) method was recently developed as an efficient system for gene delivery into plant cells. However, the gene transfer efficiency of CAPT i...
We investigated various parameters of the PBPT method to increase transient gene expression efficiency in Brassica campestris. The optimal conditions for PBPT were a single bombardment with gold parti...
Ocular gene therapy represents fertile ground for rapid innovation, with ever-expanding therapeutic strategies, molecular targets, and indications....
Potential indications for ocular gene therapy have classically focused on inherited retinal disease (IRD) but more recently include acquired retinal diseases, such as neovascular age-related macular d...
The success of treatment for IRD, paired with the promise of clinical research in acquired retinal diseases and in administration techniques, has raised the possibility of in-office gene therapy for c...
Selective gene delivery to a cell type of interest utilizing targeted lentiviral vectors (LVs) is an efficient and safe strategy for cell and gene therapy applications, including chimeric antigen rece...
It is known that the human cellular models of Alzheimer's disease (AD) and tauopathy can only recapitulate the very early stage of the disease. To overcome these limitations, we developed a technology...
Despite advances in gene therapy, the lack of safe and efficient gene delivery systems limited the clinical effectiveness of gene therapy. Due to the inherent potential of bacteria, they can be consid...
The invasin (inv) gene from Yersinia pseudotuberculosis and the listeriolysin (hlyA) gene from Listeria monocytogenes were isolated by PCR assay and inserted into a pACYCDuet-1 vector. The recombinant...
A fluorescence microscope showed that, in contrast to the control group, the manipulated E. coli were able to penetrate the cells and transport the plasmid pEGFP-C1 to the target cells. Flow cytometry...
This study shows that genetically engineered E. coli can enter cells, transport cargo into cells, and induce gene expression in the target cell. In addition, flow cytometry shows that the gene transfe...
For the past decades, gene editing demonstrated the potential to attenuate each of the root causes of genetic, infectious, immune, cancerous, and degenerative disorders. More recently, Clustered Regul...
Gene delivery vectors are a crucial determinant for gene therapeutic efficacy. Usually, it is necessary to use an excess of cationic vectors to achieve better transfection efficiency. However, it will...
This review will discuss the fluorophilic effects that impact gene delivery efficiency, and chemical modification approaches for fluorination. Next, recent advances and applications of fluorinated pol...
Fluorinated vectors are a promising candidate for gene delivery. However, it still needs further studies to obtain pure and well-defined fluorinated polymers, guarantee the biosafety, and clarify the ...
Recent years have seen remarkable advances in the field of drug and gene delivery systems, revolutionizing the way we approach therapeutic treatments [...]....
Gene therapy is a technique involving the modification of an individual's genes for treating a particular disease. The key to effective gene therapy is an efficient carrier delivery system. Viral vect...